Trial
NCT02078843
Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Insel Gruppe AG, University Hospital Bern
Collaborators
University of Lausanne Hospitals; University Hospital, Basel, Switzerland; University of Bern; SWAN Isotopen AG, Bern
Condition
Gastroenteropancreatic Neuroendocrine Tumors
Intervention
Gallium-68-DOTATATE PET/CT (index test)
Why stopped
Superiority of one imaging method
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-07